This review provides a profound insight into p53-dependent metabolic actions directed towards promotion of insulin resistance as well as presenting experimental data regarding obesity-induced p53-mediated metabolic abnormalities. This evidence concerns the gene TP53 and obesity due to melanocortin 4 receptor deficiency.